Cargando…
Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II
The anti-hyperglycaemic drug metformin has important anticancer properties as shown by the direct inhibition of cancer cells proliferation. Tumor cells avidly use glucose as a source for energy production and cell building blocks. Critical to this phenotype is the production of glucose-6-phosphate (...
Autores principales: | Salani, Barbara, Marini, Cecilia, Rio, Alberto Del, Ravera, Silvia, Massollo, Michela, Orengo, Anna Maria, Amaro, Adriana, Passalacqua, Mario, Maffioli, Sara, Pfeffer, Ulrich, Cordera, Renzo, Maggi, Davide, Sambuceti, Gianmario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691576/ https://www.ncbi.nlm.nih.gov/pubmed/23797762 http://dx.doi.org/10.1038/srep02070 |
Ejemplares similares
-
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer
por: Marini, Cecilia, et al.
Publicado: (2013) -
IGF-IR Internalizes with Caveolin-1 and PTRF/Cavin in Hacat Cells
por: Salani, Barbara, et al.
Publicado: (2010) -
Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
por: Marini, Cecilia, et al.
Publicado: (2021) -
Estimate of FDG Excretion by means of Compartmental Analysis and Ant Colony Optimization of Nuclear Medicine Data
por: Garbarino, Sara, et al.
Publicado: (2013) -
Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells
por: Bruno, Silvia, et al.
Publicado: (2015)